Joung; Hyouk

Patent Applications and Registrations

Patent applications and USPTO patent grants for Joung; Hyouk.The latest application filed is for "pharmaceutical composition for preventing and treating inflamatory disease or asthma containing an extract of decaspermum fruticosum".

Company Profile

0.8.6

Joung; Hyouk - Daejeon N/A KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity Grant 8,974,837 - Lee , et al. March 10, 2	2015-03-10
Pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma containing an extract of Decaspermum fruticosum Grant 8,883,226 - Oh , et al. November 11, 2	2014-11-11
Pharmaceutical Composition For Preventing And Treating Inflamatory Disease Or Asthma Containing An Extract Of Decaspermum Fruticosum App 20130323331 - Oh; Sei Ryang ; et al.	2013-12-05
Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity Grant 8,455,541 - Lee , et al. June 4, 2	2013-06-04
Pharmaceutical Composition Comprising An Extract Of Pseudolysimachion Longifolium And The Catalpol Derivatives Isolated Therefrom Having Antiinflammatory, Antiallergic And Antiasthmatic Activity App 20120184499 - LEE; Hyeong Kyu ; et al.	2012-07-19
Pharmaceutical Composition Comprising An Extract Of Pseudolysimachion Longifolium And The Catalpol Derivatives Isolated Therefrom Having Antiinflammatory, Antiallergic And Antiasthmatic Activity App 20120183632 - LEE; Hyeong Kyu ; et al.	2012-07-19
Pharmaceutical composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity Grant 8,168,235 - Lee , et al. May 1, 2	2012-05-01
Transformed plant cell expressing tandem repeats of beta-amyloid gene and plant produced by the same Grant 7,700,837 - Kim , et al. April 20, 2	2010-04-20
Pharmaceutical Composition Comprising An Extract Of Pseudolysimachion Longifolium And The Catalpol Derivatives Isolated Therefrom Having Antiinflammatory, Antiallergic And Antiasthmatic Activity App 20090324750 - Lee; Hyeong Kyu ; et al.	2009-12-31
Transformed Plant Cell Expressing Tandem Repeats of Beta-Amyloid Gene and Plant Produced by the Same App 20080213340 - Kim; Hyun Soon ; et al.	2008-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.